Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
189.00    -3.60 (-1.87%)
Bid:
189.20
Ask:
190.60
Spread: 1.40 (0.74%)
Market Cap: £504.78m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

Interim Management Statement

5 Nov 2014 07:00

RNS Number : 1522W
Costain Group PLC
05 November 2014
 



 

Costain Group PLC

("Costain" or "the Group")

 

Interim Management Statement

 

Costain, the engineering solutions provider, today issues its Interim Management Statement covering the period from 1 July 2014 to the current date.

 

The Group is today hosting a visit for investors and analysts to Paddington and Reading and later to its Maidenhead office. No new material information will be disclosed.

 

Update

 

Following a strong performance in the first half of the year, Costain continues to perform well and in line with the Board's expectations.

 

The Group is benefiting from its unique and well-positioned strategy, focusing on major customers who are investing billions of pounds meeting national needs in energy, water and transportation, and who require solutions to their complex business challenges.

 

Costain's reputation for developing and implementing innovative engineering led solutions through a range of integrated services and the benefits of the successful capital raise of £70.3 million (net of expenses) in March are enabling the Group to continue to take advantage of the opportunities created by its strategy and to continue to win significant contracts and extensions.

 

Additional work won during the period under review, demonstrating the range of skills and capabilities of the Group, include:

 

· Southern Water's 2015 - 2020 (AMP6) investment programme;

· Two Smart Motorway Scheme contracts on the M1 for the Highways Agency;

· Upgrade of the Dimlington gas terminal for Perenco; and

· Appointment by BAE Systems, as announced separately today, as one of its framework contractors on the redevelopment of its submarine site, in Barrow-in-Furness, Cumbria.

 

Order book

 

The Group's forward order book has increased further since thehalf-year, and currently stands at a new record level of £3.3 billion.

 

As well as including over £900 million of revenues secured for 2015 (2013: over £700 million secured for 2014), the order book also provides good long-term visibility with over £2.2 billion of revenues secured for 2016 and beyond.

 

In addition to the record order book, the Group has a strong preferred bidder position of over £400 million, and the level of tendering activity across all its target markets remains high.

 

The increasingly strategic nature of our long-term customer relationships has ensured that over 90% of the order book comprises repeat business and is in target cost, cost reimbursable, collaborative forms of contract providing increased visibility over long-term margins at lower risk.

 

Financial position

 

The Group has a robust financial position with a strong net cash position in line with expectations.

 

Outlook

 

The Group is on track to deliver a result for the current year in line with the Board's expectations and, with a record order book, strong cash position and high level of tendering activity, is well positioned to deliver growth over the medium term.

 

 

5 November 2014

 

Enquiries:

 

Costain

Tel: 01628 842 444

Andrew Wyllie, Chief Executive

Tony Bickerstaff, Finance Director

Graham Read, Communications Director

Instinctif Partners

Tel: 020 7457 2020

Mark Garraway

Helen Tarbet

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDZLFBZFFBFBD
Date   Source Headline
30th Nov 201610:11 amRNSHolding(s) in Company
30th Nov 20168:00 amRNSTotal Voting Rights
29th Nov 20163:36 pmRNSResult of Placing
29th Nov 20162:42 pmRNSProposed Placing
21st Nov 20167:00 amRNSContract
15th Nov 20167:00 amRNSContract
4th Nov 20161:48 pmRNSDirector/PDMR Shareholding
1st Nov 20169:37 amRNSTotal Voting Rights
31st Oct 20167:00 amRNSTotal Voting Rights
27th Oct 20167:00 amRNSBlock Listing Application
19th Oct 20164:36 pmRNSDividend Declaration - Amendment
18th Oct 20168:00 amRNSDividend - Scrip Alternative
27th Sep 201612:38 pmRNSDirector/PDMR Shareholding
23rd Sep 201611:06 amRNSHolding(s) in Company
22nd Sep 201611:43 amRNSScrip Dividend Reference Price
20th Sep 201612:57 pmRNSHolding(s) in Company
6th Sep 201612:11 pmRNSDirector/PDMR Shareholding
1st Sep 201612:13 pmRNSHolding(s) in Company
30th Aug 20164:28 pmRNSHolding(s) in Company
30th Aug 20164:08 pmRNSHolding(s) in Company
24th Aug 20167:00 amRNSHalf-year Report
11th Jul 201610:16 amRNSDirector Declaration
6th Jul 20167:00 amRNSAcquisition
30th Jun 201612:53 pmRNSDirector/PDMR Shareholding
30th Jun 20168:57 amRNSBlock listing Interim Review
30th Jun 20167:00 amRNSTrading Update
17th Jun 20167:00 amRNSBusiness Briefing
31st May 20169:00 amRNSTotal Voting Rights
17th May 20167:00 amRNSDividend - Scrip Alternative
16th May 20163:03 pmRNSDirector/PDMR Shareholding
5th May 20164:51 pmRNSResult of AGM
5th May 20167:01 amRNSLTIP Listing Application
5th May 20167:00 amRNSAGM Statement
25th Apr 20167:00 amRNSHolding(s) in Company
21st Apr 20162:05 pmRNSScrip Dividend Reference Price
18th Apr 201610:22 amRNSHolding(s) in Company
7th Apr 20167:00 amRNSDirector/PDMR Shareholding
6th Apr 20167:00 amRNSAppointment of Chairman Designate
4th Apr 201610:38 amRNSDirector/PDMR Shareholding
31st Mar 201610:32 amRNSNotice of AGM
2nd Mar 20167:00 amRNSFinal Results
1st Feb 20167:00 amRNSRe Contract
21st Jan 20169:07 amRNSHolding(s) in Company
11th Jan 20167:00 amRNSConfirmation of Contract Award
7th Jan 201612:17 pmRNSHolding(s) in Company
6th Jan 20167:00 amRNSTrading Update
4th Jan 20168:55 amRNSBlocklisting Interim Review
24th Dec 201512:17 pmRNSDirector/PDMR Shareholding
22nd Dec 201511:46 amRNSHolding(s) in Company
22nd Dec 20159:13 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.